Verrica Pharmaceuticals I...

0.66
0.02 (3.09%)
At close: Jan 17, 2025, 3:59 PM
0.68
2.63%
After-hours Jan 17, 2025, 05:32 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 5.12M 9.03M 12.00M n/a n/a n/a n/a n/a
Cost of Revenue 746.00K 725.00K 472.00K 229.00K 257.20K 20.29K n/a n/a
Gross Profit 4.38M 8.31M 11.53M -229.00K -257.20K -20.29K n/a n/a
Operating Income -65.76M -21.30M -30.91M -40.18M -30.08M -21.88M -4.46M -1.91M
Interest Income 2.74M 476.00K 123.00K 521.00K 1.88M 1.23M n/a n/a
Pretax Income -67.00M -24.49M -35.08M -42.69M -28.21M -20.65M -4.46M -1.91M
Net Income -67.00M -27.68M -38.90M -45.50M -27.95M -20.65M -4.46M -1.91M
Selling & General & Admin 47.30M 17.41M 26.98M 24.51M 14.64M 9.05M 727.00K 204.00K
Research & Development 20.30M 12.20M 15.93M 15.67M 15.44M 12.83M 3.73M 1.71M
Other Expenses 2.54M -58.00K n/a -1K 1.87M -1K n/a n/a
Operating Expenses 70.14M 29.60M 42.91M 40.18M 30.08M 21.88M 4.46M 1.91M
Interest Expense 3.96M 2.17M 4.29M 3.03M n/a n/a 2.00K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 70.88M 30.33M 42.91M 40.18M 30.08M 21.88M 4.46M 1.91M
Income Tax n/a 3.19M 3.82M 2.80M -257.00K 1.23M -4.46M -1.91M
Shares Outstanding (Basic) 45.34M 34.16M 27.04M 25.00M 24.90M 14.66M 19.95M 19.95M
Shares Outstanding (Diluted) 45.34M 34.16M 27.04M 25.00M 24.90M 14.66M 19.95M 19.95M
EPS (Basic) -1.48 -0.81 -1.44 -1.82 -1.12 -1.41 -0.22 -0.1
EPS (Diluted) -1.48 -0.81 -1.44 -1.82 -1.12 -1.41 -0.22 -0.1
EBITDA -62.20M -21.60M -30.31M -39.43M -30.08M -20.63M -4.46M -1.91M
Depreciation & Amortization 836.00K 718.00K 472.00K 229.00K 257.20K 20.29K 4.46M 1.91M

Create Price Alert on VRCA

Your price alert will notify you when the stock price is above 0.66.

Add to Watchlist